Healthcare Professionals
Please log in for special information and services
MUDr. Veronika Chicevicová Country Manager

“Our common objective is to develop, procedure and provide innovative treatment options for all patients, who are still waiting for hope and help in the treatment of their orphan diseases. We feel more like  partner than a vendor for both scientific community and patient organizations." 

PHARMDR. Sárka Reitlerová Marketing Manager

"It is our intention to contribute continuously to improvement of the rare disease treatment standards. Despite the organization growth we want to remain the company that is enthusiastic, pioneering, professional and empathetic, keeping the company philosophy that the patient is on the first place!"

Facts & Figures

AOP Orphan is fully dedicated to pharmaceutical and clinical development as well as commercialisation of drugs for more than 20 years already.

Our motivation at AOP Orphan is to help patients who suffer from rare diseases. We achieve this cooperating with stakeholders of the Czech health care system. Partnerships within pharmaceutical and health care industry are crucial for finding and providing solutions for patients, especially in the treatment of orphan diseases. 

Czech Republic occupies a special position among many countries where AOP Orphan is represented. In this market, the company began its development in 2003. AOP Orphan in Czech Republic is comprised of experienced and qualified team members in Marketing & Sales, and Medical for all four therapeutic divisions.

 

20,000
people
PATIENTS WITH RARE DISEASES IN Czech Republic
In Europe those diseases that occur in less than 5 per 10,000 residents are defined as rare diseases. 
According to estimates, there are approximately 20,000 patients with these diseases in the Czech Republic. Roughly 80% of rare diseases have a genetic origin. 
TREATMENTS
In Czech Republic AOP Orphan represents nineteen products. 
19
products
4
areas
four THERAPEUTIC AREAS
AOP Orphan in Czech Republic covers four treatment areas: HematoOncology, Cardiology & Pulmonology, Neurology, Metabolic Disorders as well as Intensive Care.

Vision & Mission